New: Unither Développement Bordeaux landing page to discover here
Unither Développement Bordeaux (UDB) is Unither Pharmaceuticals group’s Innovation & Development center. For more than 30 years, we are working with a panel of customers, researchers, physicians, scientists, pharmacists, from public institutions, start-ups, and small, medium and big pharmaceutical companies. Our scientific and technical expertise allow us to manage Pharmaceutical Development combining Galenic Formulation and Analytical Support starting from early stages developments, clinical trial phases, to commercial manufacturing. UDB is the ideal partner to support the manufacturing of small batches for Clinical Trials and Orphan Drugs.
Specializing in contract manufacturing, Unither ensures that its innovative galenic forms remain competitive, practical and easy to use for the patients. The development of those galenic formulations for pharmaceutical use aims to improve the lives of patients and doctors. Unither focuses on the development and manufacture of quality single-dose drugs using Blow-Fill-Seal (BFS), Preservative-free multidose (PFMD) and liquid stick-packs technologies.
Ideal for active patients' lifestyles, unit doses are dosage forms that are both easy to carry and administer as treatment products, thus significantly improving not only dosage accuracy but also patient compliance and treatment experience.
Analytical testing constantly assesses the product quality from development to final release.
Our team comprises analytical experts using regularly maintained, updated, and qualified equipment to perform the following services:
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Ce site utilise Google Analytics pour collecter des informations anonymes telles que le nombre de visiteurs du site et les pages les plus populaires.
Garder ce cookie activé nous aide à améliorer notre site Web.
Please enable Strictly Necessary Cookies first so that we can save your preferences!